Advertisement

Topics

Relvar® Ellipta® 100/25 mcg gains approval in Japan for use in patients with COPD

19:00 EST 1 Dec 2016 | GlaxoSmithKline

Original Article: Relvar® Ellipta® 100/25 mcg gains approval in Japan for use in patients with COPD

NEXT ARTICLE

More From BioPortfolio on "Relvar® Ellipta® 100/25 mcg gains approval in Japan for use in patients with COPD"

Quick Search
Advertisement